Rex is a transactional attorney who focuses on mergers and acquisitions involving independent pharmacies and other health care businesses. He represents buyers and sellers in asset and equity transactions involving community retail pharmacies, specialty pharmacies, and compounding pharmacies and advises clients on acquisitions, dispositions, ownership structures, governance matters, and related commercial arrangements. Rex guides clients through every stage of the transaction process, including structuring, due diligence, negotiation, closing, and post-closing integration.
In addition to his pharmacy and health care transactional practice, Rex counsels for-profit and not-for-profit organizations on entity formation, ownership and governance matters, and commercial contracting. He regularly advises clients on customer and vendor agreements, terms and conditions of purchase and sale, corporate governance issues, tax-exempt organization formation, and federal and state tax-exempt status. His experience also includes advising religious organizations on formations, affiliations, disaffiliations, and other organizational transactions.
Rex further represents emerging companies and investors in private placements and venture capital transactions, including National Venture Capital Association (NVCA)-style priced financing rounds.
Before practicing law, Rex spent nearly a decade with a large Boston-based health care technology company, where he worked closely with health care providers to improve operational efficiency, optimize revenue cycle performance, and implement value-based care initiatives. That experience provides him with a practical understanding of the operational, regulatory, and reimbursement challenges facing pharmacies and other health care organizations, informing his approach to complex health care transactions.